Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Prostate Cancer: Double VS triplet therapy in mHSPC - Urology Cheatsheets
Improved survival rates for veterans with de novo mHSPC - Prostate ...
NUBEQA® (darolutamide) | mHSPC
Flowchart of the proposed MHSPC algorithm | Download Scientific Diagram
APCCC 2024: Ideal Monitoring of Patients with mHSPC – What Is ...
ASCO GU 2025: Discussant: Personalizing Prostate Cancer Care for mHSPC ...
Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A ...
Strategy for mHSPC based on the tumor burden. ADT androgen-deprivation ...
The Latest Research on mHSPC
mHSPC
mHSPC Feb 2023.pptx
Possible sequencing scenarios in patients with mHSPC initially treated ...
APCCC 2024: Future Changes in the Setting of mHSPC
EAU 2025: A Case of Progression After Triplet Therapy for mHSPC ...
Proportion of patients participating in de novo mhsPC in clinical ...
ASCO 2023: Treatment and Survival of De Novo mHSPC Among African ...
Real-World Data Reveals Rise in mHSPC Treatment Intensification | GU ...
Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC - OncoDaily
AUA 2025: Systemic Treatment Prescription and Switch Patterns in mHSPC ...
Study schema. mHSPC = metastatic hormone sensitive prostate cancer ...
Completed RCTs of abiraterone acetate in patients with mHSPC ...
APCCC 2024: Management of Patients with mHSPC and Early Progression on ...
HARMONY Study Aims to Personalize PARP Inhibition in mHSPC Through ...
Evolving Standard of Care for mHSPC Prompts Interest in Deescalation ...
ESMO 2025: Invited Discussant: mHSPC in 2025: More, Less, or Smarter?
Overview of phase III randomized studies conducted of ARIs in mHSPC ...
The Current Landscape of Metastatic Hormone Sensitive Prostate Cancer ...
ASCO 2023: When More Is More: Treatment Intensification for Hormone ...
EAU 2024: Synchronous mHSPC: What Are the Treatment Options and What ...
Treatment Intensification in Metastatic Hormone Sensitive Prostate ...
EAU 2023: State-of-the-Art Lecture: Optimal Treatment Sequencing in the ...
Novel Targets and Treatment Developments in Metastatic Hormone ...
ASCO GU 2020: Treatment Selection in mHSPC: Considerations Now and ...
APCCC 2022: mHSPC: Do We Need More Granularity? Systemic Treatment ...
List of treatment options and survival rates in mHSPC. | Download ...
Prostate cancer cohorts and analysis strategy Pre-treatment plasma ...
Treatment Selection in mHSPC: ARANOTE, STOPCAP, and the Future of ...
Southern CA GU Cancer Research Forum 2024: Prostate Cancer Case Studies ...
Emerging Therapies, PEACE-1 and ARASENS in the mHSPC, mCSPC Landscapes ...
Emerging Paradigms in Metastatic Hormone-Sensitive Prostate Cancer ...
figure-3-mHSPC-treatment-utilization2x.jpg
Initial Consults and Diagnostics: How APPs Guide Patients Through Early ...
Real-World Utilization of Treatment Intensification in Metastatic ...
EAU 2023: Debate: Is There Any Added Value of Docetaxel in Combination ...
EAU 2024: State-of-the-Art Lecture: How to Personalize Treatment in ...
ASCO 2021: Can We Define the Standard of Therapy for First-Line ...
Philip Kwong教授：mHSPC诊疗的新策略和新视野丨2025浦江前列腺癌大会
First-line therapy options for metastatic hormone-sensitive prostate ...
Therapie des metastasierten hormonsensitiven Prostatakarzinoms (mHSPC ...
(PDF) Translating Clinical Evidence into Practice: Improving Patient ...
Metastatic Hormone-Sensitive Prostate Cancer: Impact of Disease Volume ...
Navigating mHSPC: Diagnostic and Imaging Strategies in Modern Practice ...
Expanding Options in mHSPC: What the Latest FDA Approval Means for ...
ASCO GU 2026: Making Sense of Many Options: Metastatic Hormone ...
Study schema and definition of outcomes. NSAA nonsteroidal ...
EAU 2024: State-of-the-Art Lecture: Local Therapy in mHSPC: Who Does ...
A review on treatment intensification and current barriers in patients ...
Real-World Evidence of Combination Therapy Use in Metastatic Hormone ...
Interdisciplinary Swiss consensus recommendations on staging and ...
ESMO 2025: Real-world Overall Survival in US-Based Patients with ...
EAU 2025: A Case of Progression after Triplet Therapy for mHSPC: PARP ...
ASCO 2023: Assessing PSA Levels as Prognostic of Overall Survival in ...
ASCO GU 2025: Choice of Androgen Receptor Pathway Inhibitors (ARPi) by ...
Advanced Prostate Cancer Information Center | ZERO Prostate Cancer
#prostatecancer #mhspc #combinationtherapies #urologists #urology # ...
Metastatic Hormone-Sensitive (mHSPC) Archives - Grand Rounds in Urology
Management of de novo Metastatic Hormone-Sensitive Prostate Cancer ...
EAU 2020: Treatment of Polymetastatic Hormone Sensitive Prostate Cancer
大咖解泌-2022 ESMO mHSPC强化治疗现状与未来趋势_研究_达罗_患者
Full article: Treatment patterns and healthcare resource utilization in ...
Ultralow Prostate-Specific Antigen (PSA) Levels and Improved ...
Controversies in metastatic hormone‐sensitive prostate cancer - Tsung ...
Comparing Costs and Health Care Resource Utilization Between nmHSPC and ...
ASCO 2023: The Relationship Between a Priori Defined Prognostic Risk ...
EAU 2025: Impact of Baseline PSA on Clinical Outcomes in Patients with ...
Newly Diagnosed mHSPC: Androgen Receptor Pathway Inhibitor Selection ...
